Indoor partitioning and potential thirdhand exposure to carbonyl flavoring agents added in e-cigarettes and hookah tobacco.
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Wu (2022)
association of electronic cigarette use with self-reported difficulty concentrating, remembering, or making decisions in US youth.
Individual Clinical
Safety
Adverse Effects
Xie (2020)
Menthol in electronic cigarettes causes biophysical inhibition of pulmonary surfactant.
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of Users
Xu (2022)
Mechanistic Effects of E-Liquids on Biofilm Formation and Growth of Oral Commensal Streptococcal Communities: Effect of Flavoring agents.
Individual Clinical
Safety
Adverse Effects
Xu (2022)
Electronic cigarette use enriches periodontal pathogens.
Individual Clinical
Safety
Adverse Effects
Xu (2022)
Emerging Oral Nicotine Products and Periodontal Diseases.
Individual Clinical
Safety
Adverse Effects
Ye (2023)
Inflammatory biomarkers and growth factors in saliva and gingival crevicular fluid of e-cigarette users, cigarette smokers, and dual smokers: a pilot study.
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Ye (2020)
Nicotine absorption Profile among Regular Users of a Pod-Based Electronic Nicotine Delivery System.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Yingst (2019)
Measurement of Electronic Cigarette Frequency of Use among Smokers Participating in a Randomized Controlled Trial.
Individual Clinical
User Topography
Yingst (2020)
association between electronic nicotine delivery systems and electronic non-nicotine delivery systems with initiation of tobacco use in individuals aged < 20 years. a systematic review and meta-analysis.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Yoong (2021)